3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations

Despite the efforts devoted to drug discovery and development, the number of new drug approvals have been decreasing. Specifically, cardiovascular developments have been showing amongst the lowest levels of approvals. In addition, concerns over the adverse effects of drugs to the cardiovascular syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Marei, Isra, Abu Samaan, Tala, Al-Quradaghi, Maryam Ali, Farah, Asmaa A., Mahmud, Shamin Hayat, Ding, Hong, Triggle, Chris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931492/
https://www.ncbi.nlm.nih.gov/pubmed/35310996
http://dx.doi.org/10.3389/fcvm.2022.847554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931492/
https://www.ncbi.nlm.nih.gov/pubmed/35310996
http://dx.doi.org/10.3389/fcvm.2022.847554

Ejemplares similares